TSZY(SZ:002872) Zheng Quan Zhi Xing·2025-07-11 16:26Group 1 - The legal opinion letter is issued by Beijing Zhongyin Law Firm regarding the second extraordinary general meeting of shareholders of Tian Sheng Pharmaceutical Group Co., Ltd. scheduled for July 2025 [2][3] - The meeting was convened by the company's sixth board of directors, chaired by Liu Shuang, and the procedures for convening and holding the meeting were in compliance with relevant laws and regulations [4][5] - The notice for the meeting was published on June 25, 2025, detailing the time, location, convenor, agenda, and voting procedures [3][5] Group 2 - A total of 132 shareholders attended the meeting, representing 128,617,946 shares, which is 40.4459% of the total voting shares [6][7] - The attendees included 8 shareholders present at the venue and 124 participating via online voting [7] - The qualifications of the attendees and the convenor were verified to be in accordance with the Company Law and the company's articles of association [6][8] Group 3 - The meeting reviewed several proposals, with voting results showing that 123,441,816 shares (95.9756%) approved the proposals, while 5,158,130 shares (4.0104%) opposed, and 18,000 shares abstained [8][9] - The voting procedures followed the company's articles of association, and the results were announced immediately after the voting concluded [9] - The legal opinion concludes that the meeting's convening, attendance, and voting procedures complied with the Company Law and the company's regulations, rendering the results valid [9][10]